Catalyst invests in supply-constrained markets where its team of 25 dedicated IOS professionals utilize institutional ...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) saw a minor decline of 3% over the past month amidst a backdrop of broader market volatility triggered by new tariffs and economic uncertainties. Despite the ...

Catalyst OrthoScience Inc. ("Catalyst"), a private medical technology leader focused on shoulder arthroplasty, the fastest ...

It has been about a month since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares have added about 14.7% in that time frame, outperforming the S&P 500. Will the recent positive ...

In its fourth quarter 2024 investor letter, Renaissance Investment Management Small Cap Growth Strategy emphasized stocks such as Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Catalyst ...